Investing Ideas
/
Australian Pharmaceuticals & Biotech High Insider Buying

Header cover image

Australian Pharmaceuticals & Biotech High Insider Buying

UPDATED Apr 15, 2024

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

12 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	MSB Mesoblast	AU$0.77	-15.4%	-22.6%	AU$946.3m	AU$1.10	PS75.5x	E64.4%	n/a
	ARX Aroa Biosurgery	AU$0.54	-6.1%	-48.3%	AU$189.3m	AU$1.02	PS3.1x	E115.3%	n/a
	DXB Dimerix	AU$0.29	1.8%	190.0%	AU$164.9m	n/a	PS17.5x	n/a	n/a
	PAA PharmAust	AU$0.32	-9.9%	233.3%	AU$132.1m	n/a	PS34x	n/a	n/a
	VLS Vita Life Sciences	AU$2.34	2.6%	64.8%	AU$129.9m	n/a	PE14.4x	n/a	3.8%
	GSS Genetic Signatures	AU$0.70	0.7%	-17.2%	AU$129.6m	n/a	PS8.2x	E74.6%	n/a
	ALA Arovella Therapeutics	AU$0.11	0%	35.8%	AU$110.3m	n/a	PS58.6x	n/a	n/a
	SNT Syntara	AU$0.017	-10.5%	-71.2%	AU$20.3m	n/a	PS1.1x	E17.7%	n/a
	GTG Genetic Technologies	AU$0.17	22.2%	-52.9%	AU$19.0m	AU$1.00	PS1.9x	E130.5%	n/a
	RNO Rhinomed	AU$0.04	-7.0%	-55.6%	AU$11.5m	n/a	PS1.4x	n/a	n/a
	ILA Island Pharmaceuticals	AU$0.06	-9.1%	-18.9%	AU$6.8m	n/a	PS7.1x	E0.8%	n/a
	IXC Invex Therapeutics	AU$0.085	1.2%	-80.7%	AU$6.4m	n/a	PS524.7x	n/a	n/a

Page 1 of 1